rh-MBL (Newsummit/Seoul National University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerh-MBL (Newsummit/Seoul National University)
Drug Alias NameRecombinant Human Mannose-Binding Lectin (Newsummit/Seoul National University)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMannose-binding protein C stimulants
TargetsMannose-binding protein C
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Xinshengyuan Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeoul National UniversityShanghai Xinshengyuan Biological Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A